AstraZeneca CEO Pascal Soriot breaks down data on new 'transformative' breast cancer drug
Вставка
- Опубліковано 5 чер 2022
- Pascal Soriot, AstraZeneca CEO, joins 'Squawk on the Street' to discuss why company data around its breast cancer drug was so well received, the next steps for other tumor types and more. For access to live and exclusive video from CNBC subscribe to CNBC PRO: cnb.cx/2NGeIvi
» Subscribe to CNBC TV: cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: www.cnbc.com/2020/09/29/the-n...
Connect with CNBC News Online
Get the latest news: www.cnbc.com/
Follow CNBC on LinkedIn: cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Instagram: cnb.cx/InstagramCNBC
www.cnbc.com/select/best-cred...
#CNBC
#CNBCTV
Well done Sir Clot Shot
* ALPP... Revenue Up 195 % in 1st qt 2022. Alpine 4 Holdings. U.S. Manuf. 11 Subsidiaries. Electronics, Drones, EV Parts, New Superior tech RCA Commercial Graphene batteries.
* FFIE.. Up 53 % Month. Faraday Future FF 91 Ultra Premium Luxury AI tech Spa Function 1,050 hp $ 300,000 SUV EV by Sept 2022.
🔆 *The whole truth about the coronavirus. Watch the video you will be shocked* EVERYDAYS.ML “Poverty is nothing more than the result of our laziness or indifference.” - Napoleon Hill